EW
ABBV icon

Element Wealth’s AbbVie ABBV Stock Holding History

Element Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Sell
5,550
-10
-0.2% -$2.22K 0.5% 54
2025
Q4 		$1.27M Buy
5,560
+76
+1% +$17.3K 0.52% 50
2025
Q3 		$1.27M Buy
5,484
+166
+3% +$33.8K 0.55% 47
2025
Q2 		$987K Buy
5,318
+12
+0.2% +$2.23K 0.45% 52
2025
Q1 		$1.11M Sell
5,306
-99
-2% -$19.2K 0.6% 40
2024
Q4 		$960K Buy
5,405
+77
+1% +$14.2K 0.5% 39
2024
Q3 		$1.05M Sell
5,328
-39
-0.7% -$7.28K 0.56% 37
2024
Q2 		$921K Buy
5,367
+10
+0.2% +$1.66K 0.52% 40
2024
Q1 		$976K Buy
5,357
+7
+0.1% +$1.21K 0.57% 36
2023
Q4 		$829K Sell
5,350
-40
-0.7% -$5.83K 0.52% 37
2023
Q3 		$803K Buy
5,390
+14
+0.3% +$2.06K 0.58% 33
2023
Q2 		$724K Sell
5,376
-67
-1% -$9.82K 0.5% 37
2023
Q1 		$867K Sell
5,443
-159
-3% -$24.3K 0.65% 31
2022
Q4 		$905K Sell
5,602
-236
-4% -$36.2K 0.74% 22
2022
Q3 		$783K Buy
5,838
+36
+0.6% +$5.17K 0.72% 22
2022
Q2 		$889K Buy
5,802
+81
+1% +$12.4K 0.88% 21
2022
Q1 		$927K Sell
5,721
-29
-0.5% -$4.21K 0.75% 22
2021
Q4 		$779K Buy
5,750
+23
+0.4% +$2.72K 0.59% 28
2021
Q3 		$618K Buy
5,727
+81
+1% +$9.26K 0.49% 33
2021
Q2 		$636K Buy
5,646
+73
+1% +$8.22K 0.5% 34
2021
Q1 		$603K Sell
5,573
-26
-0.5% -$2.78K 0.5% 31
2020
Q4 		$600K Buy
5,599
+23
+0.4% +$2.21K 0.56% 32
2020
Q3 		$488K Buy
5,576
+52
+0.9% +$4.9K 0.52% 33
2020
Q2 		$542K Buy
5,524
+296
+6% +$26.1K 0.62% 28
2020
Q1 		$398K Buy
5,228
+2,056
+65% +$175K 0.55% 36
2019
Q4 		$281K Buy
+3,172
New +$263K 0.29% 57

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Element Wealth's ABBV Position: Q1 2026 in Review

Element Wealth reduced its AbbVie (ABBV) stake by 0.18% in Q1 2026, selling an estimated $2.22K and leaving 5,550 shares worth $1.21M. The position accounts for 0.5% of the portfolio, ranked #54.

Element Wealth first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.27M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Element Wealth held 5,550 shares of AbbVie worth $1.21M as of Q1 2026.
  • Element Wealth sold 10 AbbVie shares in Q1 2026, an estimated $2.22K.
  • AbbVie made up 0.5% of Element Wealth's portfolio in Q1 2026, its #54 holding.
  • Element Wealth first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Element Wealth's AbbVie position peaked at $1.27M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Element Wealth's 13F filing for Q1 2026, filed 4 May 2026.